Yale Podnos

Chief Medical Officer, Starling Oncology, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.3M

Companies

Latest trade

Jul 14, 2026

Companies

Starling Oncology, Inc.Chief Medical Officer −$0.3M

Trades

STLN Sold 23,452 shares at $6.41 · planned $0.2M Jul 14

STLN Sold 23,451 shares at $5.38 · planned $0.1M Jun 8

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.